Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans
- PMID: 344213
- PMCID: PMC414112
- DOI: 10.1128/iai.19.2.499-509.1978
Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans
Abstract
Cutaneous infection of mice with Candida albicans elicited a predominantly acute inflammatory response, stimulated the production of precipitating antibodies, and conferred protection against subsequent intravenous challenge with the same organism. The acute inflammatory skin reaction seen after cutaneous infection suggested a predominantly humoral response to Candida. Animals infected cutaneously a second time with viable C. albicans developed larger skin lesions than animals infected only once, and the twice-infected animals were more resistant to an intravenous challenge as well. The cutaneous inoculation of mice with heat-killed C. albicans was less effective in stimulating antibody production, in eliciting the inflammatory response, and in inducing a protective response demonstrable by intravenous challenge with viable Candida. This model of experimental candidiasis represents a reproducible means of studying a protective immune response to the organism.
Similar articles
-
Effects of cyclophosphamide on murine candidiasis.Infect Immun. 1980 Feb;27(2):376-86. doi: 10.1128/iai.27.2.376-386.1980. Infect Immun. 1980. PMID: 6991413 Free PMC article.
-
Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Infect Immun. 2002 Oct;70(10):5462-70. doi: 10.1128/IAI.70.10.5462-5470.2002. Infect Immun. 2002. PMID: 12228271 Free PMC article.
-
Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein.Infect Immun. 1985 Jul;49(1):172-81. doi: 10.1128/iai.49.1.172-181.1985. Infect Immun. 1985. PMID: 4008047 Free PMC article.
-
Adaptive immune responses to Candida albicans infection.Virulence. 2015;6(4):327-37. doi: 10.1080/21505594.2015.1004977. Epub 2015 Jan 21. Virulence. 2015. PMID: 25607781 Free PMC article. Review.
-
Protective antigens and mechanisms of anti-Candida immunity.Nihon Ishinkin Gakkai Zasshi. 2000;41(4):219. doi: 10.3314/jjmm.41.219. Nihon Ishinkin Gakkai Zasshi. 2000. PMID: 11064318 Review.
Cited by
-
Evidence for macrophage-mediated protection against lethal Candida albicans infection.Infect Immun. 1986 Feb;51(2):668-74. doi: 10.1128/iai.51.2.668-674.1986. Infect Immun. 1986. PMID: 3943907 Free PMC article.
-
Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice.Infect Immun. 1978 Sep;21(3):729-37. doi: 10.1128/iai.21.3.729-737.1978. Infect Immun. 1978. PMID: 309437 Free PMC article.
-
Cellular immunity in a cutaneous model of cryptococcosis.Infect Immun. 1983 Jun;40(3):1052-9. doi: 10.1128/iai.40.3.1052-1059.1983. Infect Immun. 1983. PMID: 6343238 Free PMC article.
-
Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans.Antimicrob Agents Chemother. 1987 May;31(5):691-7. doi: 10.1128/AAC.31.5.691. Antimicrob Agents Chemother. 1987. PMID: 3300536 Free PMC article.
-
Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans.Infect Immun. 1980 Oct;30(1):78-89. doi: 10.1128/iai.30.1.78-89.1980. Infect Immun. 1980. PMID: 7002793 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources